Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Correlation Between Umbilical Resistance Index and Fetal Growth

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02842346
Recruitment Status : Completed
First Posted : July 22, 2016
Last Update Posted : July 25, 2016
Sponsor:
Information provided by (Responsible Party):
Mehdi Kehila, University Tunis El Manar

Brief Summary:
The aim of our study was to investigate the correlation between the umbilical resistance index and weight gain during the third trimester of low-risk pregnancies.

Condition or disease Intervention/treatment
Umbilical Doppler Other: ultrasonography

Layout table for study information
Study Type : Observational
Actual Enrollment : 77 participants
Time Perspective: Prospective
Official Title: Correlation Between Umbilical Resistance Index and Fetal Growth: a Pilot Study
Study Start Date : November 2015
Actual Primary Completion Date : January 2016
Actual Study Completion Date : January 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ultrasound




Primary Outcome Measures :
  1. fetal growth [ Time Frame: at birth ]
    . During routine prenatal third trimester ultrasonography patients had a fetal weight estimation and measurement of the umbilical resistance index. After delivery we took note of the weight at birth, the term of the delivery, and the time interval between the ultrasound and the delivery, and then we calculated the weight gain on a weekly basis.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Any pregnant patient with a normally progressing pregnancy and reporting for a prenatal screening ultrasound between 31 and 34 weeks amenorrhea.
Criteria

Inclusion Criteria:

  • Any pregnant patient with a normally progressing pregnancy and reporting for a prenatal screening ultrasound between 31 and 34 weeks amenorrhea.

Exclusion Criteria:

  • -The lack of an ultrasound carried out during the first trimester to confirm the term of the pregnancy.
  • A medical condition in the mother: diabetes, high blood pressure or a known chronic illness.
  • A medical condition in the fetus: suspicion of fetal hypotrophy (fetal biometrics lower than the 10th percentile), a birth defect (a chromosomal abnormality) during the pregnancy.
  • Patients with tobacco addiction.
  • A body mass index (BMI) ≥ 30 before the pregnancy.
  • Multiple pregnancies
  • A gap of less than 4 weeks between the date of the ultrasound and the date of delivery.
Publications:
Layout table for additonal information
Responsible Party: Mehdi Kehila, Dr, University Tunis El Manar
ClinicalTrials.gov Identifier: NCT02842346    
Other Study ID Numbers: CMNTIR
First Posted: July 22, 2016    Key Record Dates
Last Update Posted: July 25, 2016
Last Verified: July 2016
Keywords provided by Mehdi Kehila, University Tunis El Manar:
Ultrasound; umbilical Doppler; resistance index; fetal growth